Assessing the safety of bladder-preserving therapy as an alternative to surgical intervention in elderly patients with muscle invasive bladder cancer.
Christopher R KollerJacob W GreenbergCaleb NataleL Spencer KranePublished in: Urologia (2024)
Octogenarians should be offered definitive local therapy for their localized bladder cancer including RC and chemotherapy. Bladder-sparing alternatives should be reserved for patients unfit for surgery.
Keyphrases
- muscle invasive bladder cancer
- end stage renal disease
- spinal cord injury
- randomized controlled trial
- ejection fraction
- newly diagnosed
- minimally invasive
- locally advanced
- peritoneal dialysis
- prognostic factors
- coronary artery bypass
- stem cells
- patient reported outcomes
- mesenchymal stem cells
- radiation therapy
- robot assisted
- coronary artery disease
- atrial fibrillation